share_log

Wells Fargo Downgrades Sangamo Therapeutics to Equal-Weight, Announces $1 Price Target

Wells Fargo Downgrades Sangamo Therapeutics to Equal-Weight, Announces $1 Price Target

富国银行将Sangamo Therapeutics的评级下调至同等权重,宣布1美元的目标股价
Benzinga ·  2023/11/06 08:21

Wells Fargo analyst Jim Birchenough downgrades Sangamo Therapeutics (NASDAQ:SGMO) from Overweight to Equal-Weight and announces $1 price target.

富国银行分析师吉姆·伯奇诺将Sangamo Therapeutics(纳斯达克股票代码:SGMO)的评级从增持下调至同等权重,并宣布了1美元的目标股价。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发